Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Teva and Medincell partnership leads to FDA approval of Weltruza for schizophrenia treatment.
Contract Type
partnership
Tel AvivManufacturingBiotechnologyHealth CarePharmaceuticalDescription
Teva has received FDA approval for Weltruza, a once-monthly injection for treating schizophrenia, developed in partnership with Medincell. This is the second approved product from their collaboration, which aims to enhance treatment adherence in chronic psychiatric conditions.
Related People
Agreement Insights
What this usually meansTeva signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.